Relay Therapeutics, Inc.
RLAY
$12.44
-$0.34-2.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.90% | 27.78% | 15.84% | 23.68% | 5.31% |
| Total Depreciation and Amortization | -58.28% | -55.10% | -45.28% | -26.75% | -13.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.97% | -20.24% | -23.45% | 31.68% | -18.27% |
| Change in Net Operating Assets | 179.04% | -294.55% | 54.29% | -114.86% | -289.03% |
| Cash from Operations | 30.18% | 22.47% | 17.27% | 16.06% | -45.48% |
| Capital Expenditure | -- | -- | 100.44% | -136.36% | 78.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.22% | 22.30% | 131.54% | 64.99% | 248.05% |
| Cash from Investing | -22.52% | 22.29% | 131.49% | 64.97% | 303.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 16.75% | -99.99% | -57.65% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 16.75% | -99.99% | -57.65% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 492.16% | 69.83% | -226.82% | 209.59% | -436.75% |